Emergence of colistin resistance during treatment of recurrent pneumonia caused by carbapenemase producing Klebsiella pneumoniae
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 94 (4) , 407-409
Abstract
No abstract availableKeywords
Funding Information
- University of Antwerp Research (BOF-DOCPRO 2012-27450)
This publication has 8 references indexed in Scilit:
- Towards Understanding MCR-like Colistin ResistanceTrends in Microbiology, 2018
- Whole genome sequencing options for bacterial strain typing and epidemiologic analysis based on single nucleotide polymorphism versus gene-by-gene–based approachesClinical Microbiology and Infection, 2018
- Evaluation of three broth microdilution systems to determine colistin susceptibility of Gram-negative bacilliJournal of Antimicrobial Chemotherapy, 2018
- Molecular mechanisms of polymyxin resistance: knowns and unknownsInternational Journal of Antimicrobial Agents, 2016
- Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methodsJournal of Applied Microbiology, 2016
- Rapid Detection of Carbapenemase-producing EnterobacteriaceaeEmerging Infectious Diseases, 2012
- Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011Eurosurveillance, 2012
- Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patientsClinical Microbiology and Infection, 2011